tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Sel Hardy, 1 are a HOLD (100%).
Analyst Sel Hardy, currently employed at CFRA,
Sel Hardy’s has documented 2 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PFE, Pfizer at 07-Oct-2024.
Analyst best performing recommendations are on PFE (PFIZER).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 22-Feb-2024
$35
$10.46 (42.62%)
$36
17 days ago
(13-Jul-2026)
20/29 (68.97%)
$10.52 (42.97%)
664
0.88
Buy Since 18-Nov-2021
$30
$5.46 (22.25%)
$30
17 days ago
(13-Jul-2026)
0/19 (0%)
$5.52 (22.55%)
0
Hold Since 30-Jul-2019
$26
$1.46 (5.95%)
$26
20 days ago
(10-Jul-2026)
5/7 (71.43%)
$1.83 (7.57%)
581
0.56
Hold Since 01-Jun-2020
$28
$3.46 (14.10%)
$30
22 days ago
(08-Jul-2026)
9/18 (50%)
$3.95 (16.42%)
1020
0.55
Buy Since 17-Mar-2026
$28
$3.46 (14.10%)
$32
24 days ago
(06-Jul-2026)
0/3 (0%)
$4.28 (18.04%)
0
What Year was the first public recommendation made by Sel Hardy?
